Abstract
Clopidogrel is the medication of choice, associated with acetylsalicylic acid (ASA), on the medical therapy of patients suffering of Acute Coronary Syndromes, and also on those submitted to percutaneous coronary intervention with stents. Despite this, several studies have demonstrated great variability in individual response to the drug, with special interest in drug interaction with the …